StockNews.com upgraded shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) to a sell rating in a research report released on Friday. A number of other research firms also recently weighed in on SNDX. Scotiabank decreased their target price on shares of Syndax Pharmaceuticals from $39.00 to $36.00 in a research report on Tuesday, October 3rd. […]
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eleven brokerages that are currently covering the firm, MarketBeat reports. Eleven equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have covered the stock […]
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been assigned an average rating of “Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. Eleven equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued a report […]
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have received an average rating of “Buy” from the eleven analysts that are covering the company, MarketBeat.com reports. Eleven equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have updated their coverage on the stock […]
Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 1.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,492 shares of the company’s stock after purchasing an additional 615 shares […]